NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
January 10, 2006 • Volume 3 / Number 2 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Abdominal Chemotherapy for Ovarian Cancer Improves Survival

Director's Update
Supporting Cancer Drug Development

Spotlight
Understanding the Legacy of Nuclear Testing

Cancer Research Highlights
Immune Response in Colorectal Tumors Linked to Longer Survival

Letrozole Superior to Tamoxifen for Breast Cancer

Analyses of Lymphoma Incidence Trends by Subtype Suggest Priorities for Future Research

Cervical Cancer Cells Can Cause Trouble Years Later

Featured Clinical Trial
Targeted Therapy for Mantle Cell Lymphoma

FDA Update
FDA Approves Lenalidomide for MDS

Funding Opportunities

CCR Grand Rounds

Notes
Hooven Named Deputy Director for Management

FY 2006 NCI Budget Update

TRWG Seeks Input

Nanotech Seminar Set for January 24

NCI Listens and Learns

Community Update
HINTS Delivers Open-Access Data on Online Behavior

Bulletin Archive

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities

CCR Grand Rounds
January 17: Dr. Tom Misteli, Principal Investigator, Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, NCI. "Beyond the Genome Sequence: Nuclear Architecture in Health and Disease"

January 24: Dr. Myles A. Brown, Chief, Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute. "Genome-Wide Analysis of Steroid Hormone Action"

CCR Grand Rounds are held 8:30 to 9:30 a.m. at the NIH campus in Bethesda, Md., in the Clinical Center's Lipsett Amphitheater.

Training for a New Interdisciplinary Research Workforce
RFA-RM-06-006

Letter of Intent Receipt Date: Feb. 14, 2006.

Application Receipt Date: Apr. 7, 2006.

This is a renewal of RFA-RM-04-015. This funding opportunity will use the R90 and T90 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3316. Inquiries: Dr. Allison L. Chausmer - achausme@nida.nih.gov

Innovations in Biomedical Computational Science and Technology Initiative (SBIR)
PAR-06-088

Application Receipt Date: Feb. 26, 2006.

This is a renewal of PAR-03-119. This funding opportunity will use the R43 and R44 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3314. Inquiries: Dr. Peter Lyster - lysterp@mail.nih.gov

Innovations in Biomedical Computational Science and Technology Initiative (SBIR)
PAR-06-089

Application Receipt Date: Feb. 26, 2006.

This is a renewal of PAR-03-119. This funding opportunity will use the R41 and R42 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3315. Inquiries: Dr. Peter Lyster - lysterp@mail.nih.gov

Research on Clinical Decision Making in Life-Threatening Illness
PA-06-101

Application Receipt Dates: Feb. 1, June 1, and Oct. 1, 2006; Feb. 1, June 1, and Oct. 1, 2007; Feb.1, June 1, and Oct 1, 2008.

This is a renewal of PA-02-118. This funding opportunity will use the R21 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3317. Inquiries: Dr. Wendy Nelson - nelsonw@mail.nih.gov

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov